Cancer Research International Training and Intervention Consortium (CRITIC)

癌症研究国际培训和干预联盟 (CRITIC)

基本信息

  • 批准号:
    8794594
  • 负责人:
  • 金额:
    $ 75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-17 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed Cancer Consortium focuses on the intervention of transmission and infection by two etiologic viral agents of the two most common AIDS-associated cancers, the Kaposi's sarcoma-associated human herpes virus (KSHV) and Human Papilloma Virus (HPV) in Tanzania. The objective of the Consortium is to enhance the three critical components of AIDS malignancies research infrastructure - virology, epidemiology and clinical care - by linking partners with documented strengths in these areas. In addition to deriving critical data on AIDS-associated malignancies, the Consortium will provide diverse training opportunities to increase local expertise and transfer technology. Overall, the partnership will ultimately lead to exchanges that build the technical and personnel infrastructure necessary to perform the high-quality biomedical, behavioral, and preventative biomedical research desperately needed in Tanzania. Four specific aims will be pursued: 1) Build the consortium's research capacity through long-term molecular cancer epidemiology training opportunities, with long-term training leading to two PhDs, in epidemiology and in molecular tumor virology, MS degrees in molecular tumor virology, and MPH degrees in cancer epidemiology. 2) Strengthen existing cancer research capacity through short term technical training in the US and in-country workshops targeting researchers, clinicians, and public health personnel. 3) Develop a molecular virology research laboratory component and epidemiology/biostatistics core facilities to support molecular cancer epidemiology research projects. 4) Support the development of Tanzanian research teams and increase the research productivity through supporting two hypothesis-driven research projects in the two most prevalent AIDS-associated malignancies, KS and cervical cancer. This proposed program is unique and of high impact because it builds onto a successful ongoing Fogarty program and NCI training program in sub-Saharan Africa, expanding it into a truly cross-disciplinary research and training program with different training tracks and with in-country research projects teaming Tanzanian and U.S. researchers to conduct hypothesis-driven research on KS, cervical cancer, and their respective etiologic agents.
描述(由申请人提供):拟议的癌症联盟重点关注坦桑尼亚卡波西肉瘤相关人类疱疹病毒(KSHV)和人类乳头状瘤病毒(HPV)两种最常见的艾滋病相关癌症的两种病原性病毒媒介的传播和感染的干预。该联盟的目标是加强艾滋病恶性肿瘤研究基础设施的三个关键组成部分——病毒学、流行病学和临床护理——通过将在这些领域具有文献记载优势的伙伴联系起来。除了获得与艾滋病有关的恶性肿瘤的关键数据外,该联盟还将提供各种培训机会,以增加当地的专门知识和转让技术。总的来说,这种伙伴关系最终将导致建立技术和人员基础设施的交流

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amr Soliman其他文献

Amr Soliman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amr Soliman', 18)}}的其他基金

Cancer Epidemiology Education in Special Populations Program-15
特殊人群癌症流行病学教育计划-15
  • 批准号:
    10306972
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
Seroprevalence of COVID-19 of cancer patients in Tanzania
坦桑尼亚癌症患者的 COVID-19 血清阳性率
  • 批准号:
    10202902
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
Cancer Epidemiology Education in Special Populations (CEESP)
特殊人群癌症流行病学教育 (CEESP)
  • 批准号:
    10006085
  • 财政年份:
    2018
  • 资助金额:
    $ 75万
  • 项目类别:
Cancer Epidemiology Education in Special Populations (CEESP)
特殊人群癌症流行病学教育 (CEESP)
  • 批准号:
    9766183
  • 财政年份:
    2018
  • 资助金额:
    $ 75万
  • 项目类别:
Cancer Epidemiology Education in Special Populations (CEESP)
特殊人群癌症流行病学教育 (CEESP)
  • 批准号:
    9655766
  • 财政年份:
    2018
  • 资助金额:
    $ 75万
  • 项目类别:
Cancer Epidemiology Education in Special Populations (CEESP)
特殊人群癌症流行病学教育 (CEESP)
  • 批准号:
    9550917
  • 财政年份:
    2018
  • 资助金额:
    $ 75万
  • 项目类别:
Cancer Research International Training and Intervention Consortium (CRITIC)
癌症研究国际培训和干预联盟 (CRITIC)
  • 批准号:
    8928588
  • 财政年份:
    2014
  • 资助金额:
    $ 75万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    10614262
  • 财政年份:
    2014
  • 资助金额:
    $ 75万
  • 项目类别:
LAB CORE
实验室核心
  • 批准号:
    8933319
  • 财政年份:
    2014
  • 资助金额:
    $ 75万
  • 项目类别:
BIOSTATS CORE
生物统计核心
  • 批准号:
    8933320
  • 财政年份:
    2014
  • 资助金额:
    $ 75万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 75万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 75万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 75万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 75万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了